GUIDELINES FOR REGISTRATION OF IMPORTERS AND FOR THE IMPORTATION OF MEDICINES AND RELATED PRODUCTS

Size: px
Start display at page:

Download "GUIDELINES FOR REGISTRATION OF IMPORTERS AND FOR THE IMPORTATION OF MEDICINES AND RELATED PRODUCTS"

Transcription

1 MEDICINES CONTROL AGENCY 54 Kairaba Avenue, Pipeline, The Gambia. Tel.no GUIDELINES FOR REGISTRATION OF IMPORTERS AND FOR THE IMPORTATION OF MEDICINES AND RELATED PRODUCTS Document no: MCA/IMPG/2017/1 Date of issue: 25 th July 2017 Date of adoption: 20 th January 2017 Version no: 01 Page 1 of 10

2 1. SCOPE In pursuance of Part II Section 4, sub-sections (a), (b) and (f) of the Medicines and Related Products Act 2014, these Guidelines are hereby developed to provide guidance to prospective applicants for registration as an importer and procedures for importing of products into The Gambia. Importers are required to familiarize themselves with this document and this Act before initiating product importation. 2. INTERPRETATION In these guidelines, unless the context otherwise states: - a) Agency means Medicines Control Agency (MCA) b) Applicant: Means a person, manufacturer or company who submits application for registration as an importer and requests for the issuance of an import permit for medicines and related products from the Agency c) medicinal purpose means - use for treating or preventing a disease, diagnosing or ascertaining the presence and extent of a physiological function, contraception, inducing anaesthesia, altering normal physiologic function permanently or temporarily in any way in humans. d) International Non-proprietary Name (INN) means the approved chemical name of the product. e) Generic drug means a finished product based on an active substance that is not off patent and which is marketed under a different name from that of the original branded medicinal product. f) Active Ingredient: Means a substance with a therapeutic, diagnostic or prophylactic activity used in a pharmaceutical product. Drug Substance" and "Active Substance" are synonymous to "Active Ingredient." g) Dosage Form: Formulation of an active ingredient(s) so that it can be administered to a patient in specified quantity/strength eg. tablets, capsules, injection solution, syrups, ointments, suppositories, etc. "Pharmaceutical Form" and "Finished Product" are synonymous to "Dosage Form." h) Counterfeit Medicine: Means a medicine that is deliberately and fraudulently mislabelled with respect to identity for source. Counterfeit products may be branded or generic medicines, and may include products with the correct ingredients, with the wrong ingredient, without ingredients, with insufficient active ingredient, or with fake packaging material. Page 2 of 10

3 i) Labeling: Includes any legend ( means any description accompanying an illustration), word or mark attached to, included in, belonging to or accompanying any medicine including: 1) The immediate container label 2) Cartons, wrappers and similar items, 3) Information materials such as instructional brochures and package inserts. j) Manufacturer: A company that carries out at least one step of manufacture. k) Medical Device: Means an instrument that is not a medicine, as defined herein, that is intended for use in the diagnosis, treatment, mitigation or prevention of a disease, disorder, abnormal physical or mental state, or symptoms thereof, in human or animal, or restoring, correcting, or beneficial modification of organic or mental functions in human or animal. l) Medical Supply: Means article that is intended for diagnosis, treatment, mitigation or prevention of a disease, disorder, abnormal physical or mental state, or symptoms thereof, in human or animal or restoring, correcting or beneficial modification of organic or mental functions in human or animal. This includes suturing materials, syringes, needles, bandages, gauze, cotton, artificial teeth, chemicals, and x-ray film and other similar articles. m) Medicine: Means any substance or mixture of substances intended for use in: (i) the diagnosis, treatment, mitigation or prevention of a disease, disorder, abnormal physical or mental state, or the symptoms thereof, in man or animal; or, (ii) restoring, correcting or beneficial modification of organic or mental functions in man or animal; or, (iii) medicine shall include traditional medicine, narcotic drugs, psychotropic substances, blood and blood products, vaccines, sera, and radiopharmaceuticals, but not health products as defined herein. n) Pharmaceutical Importer: Means a registered entity and licensed by MCA to procure and import medicines and related products from foreign countries and/or distribution in the Gambia. o) Related product means an article other than medicine which includes cosmetics, homeopathic medicines, medical device, instrument or apparatus including, components, parts and accessories of it, manufactured, sold or represented for use in the diagnosis, treatment, mitigation or prevention of a disease, disorder or abnormal physical state, or the symptom of it in man or animal; 3. REQUIREMENTS 3.1 General Requirements 1. Only the following shall be registered as importers and be permitted to import medicines and related products by the Medicines Control Agency (a) Corporate bodies duly registered by the Registrar of Companies Page 3 of 10

4 (b) Registered wholesale pharmaceutical companies duly licensed by the Agency (c) Governmental (Hospitals, health facilities or similar health related institutions) and Non- Governmental Organizations (NGO s) that provide healthcare services may be permitted to import reasonable quantities on request for use only in their pharmacies and private clinics. (d) Registered Medical doctors, Dentists and Veterinary surgeons may be permitted to import reasonable quantities on special request for use only in their pharmacies and private clinics. (e) Patients with prescriptions for specialist medicines may on request import such medicines for their personal use only. 2. The above notwithstanding, importation of samples for registration, medical promotion, and/or clinical trials, as well as importation of specific prescriptions for particular patients, may be permitted after approval by the Agency. 3. All products imported shall have at least 60% of its shelf-life remaining on arrival at the port. This, notwithstanding, products with a shelf-life of less than 24 months shall have at least 80% of the shelf-life remaining on arrival at the port of entry. 4. Condoms shall be released from the port of entry based on a batch-to-batch evaluation and analysis after approval by the Agency. 5. Products containing steroids are considered as medicines and shall not be permitted to be imported and used as cosmetics. 4.0 PRODUCT IMPORT PERMIT a) Except otherwise provided by these guidelines, import permits shall be granted before the importation of a product. b) In applying for a permit, the following documents shall be submitted: (i) Three (3) copies of the supplier s invoice. (ii) Three (3) copies of appropriately filled permit application forms. c) Permits issued for importation of products shall be presented to Customs ONLY ONCE, and shall not be re-presented for a second time in case goods are short-landed. d) At the point of clearance, the clients copy of the permit should be handed over to the Customs and MCA port inspector for endorsement and clearance of goods. e) For short-landed goods, a new import permit shall be obtained from the Agency. f) Importers registration and Import Permits shall be valid for ONE CALENDAR YEAR from the date of issue. Page 4 of 10

5 g) Importers registration fees and an import permit processing fee shall be charged as indicated in the Fee Schedule of the Agency. h) Vetting and approval of an application for importation and accompanying pro-forma invoices may take up to five (5) working days i) Permits for importation of controlled drugs, psychotropics and narcotics will be processed only after approval of allocation and submission of returns on consumption. j) Applications which do not conform to any of the requirements of the Agency shall not be approved. 5.0 COMPLETION OF IMPORT PERMIT APPLICATION FORM 5.1 All import permits shall bear the (a) Full name, telephone number, fax, , postal address and premises address of the exporter and importer (b) Name/description of product (c) Total quantity of product in dosage units (d) Registration number of the product (s) (e) Name of manufacturer/country of origin (f) Batch number (g) Total CIF value (h) Name of port of shipment and approved port of entry and the date 5.2 For MEDICINES, the permit shall bear the following: (a) Full name, signature and registration number of the Superintendent Pharmacist. (b) Brand name and generic name of the product. 5.3 For non-pharmaceutical companies and products, the permit shall be signed by a duly authorized person(s). 5.4 Products imported shall be inspected by officials of the MCA at the port of entry before they are released to the importer. Page 5 of 10

6 5.5 The above notwithstanding, any statute governing importation procedures and tax liabilities shall apply to an imported product. 5.6 An application for importation of a product may be rejected for several reasons. This may include, but not limited to: (a) A product not registered with the Agency. (b) A product with a potential for abuse (c) A controlled drug, when the national quota for that particular drug is exhausted e.g. narcotic drugs and psychotropic substances. (d) A product found to be counterfeit, fake, substandard and/ or adulterated. 5.7 All importers are required to renew their company import license with the Agency annually. 6.0 SANCTIONS AND PENALTIES 6.1 Non-Compliant Products (a) The Agency may apply the following regulatory actions in case of the importation of a noncompliant product after detention and issuance of appropriate detention notice: (i) Order the re-export of the product at the cost of the importer. (ii) Confiscate a non-compliant product, which may be destroyed and the cost of destruction borne by the importer, who may be prosecuted accordingly. 6.2 Bringing Into Compliance / Rectifying non-compliant products (a) The Agency may permit an importer to bring an imported non-compliant product into compliance with the law. Any sorting, processing, labelling/ re-labelling or analysis shall be supervised by an officer of the Agency at the expense of the importer. (b) Where the non-compliant product is unregistered, the importer shall be made to submit the product for registration and pay the appropriate fees in addition to a penalty to be determined by the Agency. Page 6 of 10

7 MEDICINES CONTROL AGENCY APPLICATION FORM TO REGISTER AS AN IMPORTER OF MEDICINES AND RELATED PRODUCTS In pursuance of Part II Sections 4 sub-section (b) and (f) of the Medicines and Related products Act 2014 A PARTICULARS OF APPLICANT Name of Company Postal Address Location/Physical Address of Company Contact Details Date of Incorporation of Company Registration number of Company For pharmaceutical companies only Telephone Fax website Name of Superintendent Pharmacist Reg. No B Signature ITEMS TO BE IMPORTED (Tick as appropriate) Medicines Allopathic Date Veterinary Homeopathic Page 7 of 10

8 Herbal Food Supplements Cosmetics Medical Devices Other (Please specify Please attach a copy each of the following documents: i. Certificate of registration from the Registrar of Companies ii. Current Pharmacy Council premise license (For Medicines only). C DECLARATION of APPLICANT I/We, the undersigned, hereby declare that all information contained herein is correct and true. Name: Position/ Designation: Signature: Date:. Official Stamp Page 8 of 10

9 MEDICINES CONTROL AGENCY IMPORT PERMIT FORM FOR MEDICINES AND RELATED PRODUCTS In pursuance of Part II Section 4 sub-sections (b) and (f) of the Medicines and Related products Act 2014 Name of Importer Postal and Premises Address Name of Exporter Postal and Premises Address Tel Tel Name and description (brand, generic name & dosage form) of Product Quantity to be imported MCA Registrat ion Number Port of Shipment and expected date of Shipment Port of Entry into The Gambia and Expected date of arrival Total CIF Value Page 9 of 10

10 Name of Superintendent Pharmacist Registration Number Signature OFFICIAL STAMP Name of business owner Signature Date FOR OFFICIAL USE ONLY Vetted by (Name) Signature Designation APPROVED BY Signature OFFICIAL STAMP Executive Director CONDITIONS OF PERMIT 1. Products imported shall be inspected by officials of the Agency at the port of entry before its release. 2. Three (3) copies of the permit together with Three (3) copies of the Supplier s Invoice shall be submitted for approval. 3. Permits issued for importation of products shall be valid for only one transaction. 4. Where goods are short-landed, a new import permit shall be obtained from the Agency. 5. At the point of clearance, the clients copy of the permit should be handed over to the Customs and MCA port inspector for endorsement and clearance of goods. 6. Importers registration and import permits shall be valid for ONE CALENDAR YEAR FROM the date of issue. Page 10 of 10

GUIDELINES FOR REGISTRATION OF MEDICINES IN THE GAMBIA

GUIDELINES FOR REGISTRATION OF MEDICINES IN THE GAMBIA MEDICINES CONTROL AGENCY 54 Kairaba Avenue, Pipeline, The Gambia. Tel.no. +220 4380632 GUIDELINES FOR REGISTRATION OF MEDICINES IN THE GAMBIA Document no: MCA/MRG/2017/1 Date of issue: 25 th July 2017

More information

GUIDELINES ON THE IMPORT AND EXPORT OF REGISTERED MEDICINES

GUIDELINES ON THE IMPORT AND EXPORT OF REGISTERED MEDICINES GUIDELINES ON THE IMPORT AND EXPORT OF REGISTERED MEDICINES 1.0 INTRODUCTION 1.1. PREAMBLE The Medicines Control Authority of Zimbabwe (MCAZ) is a regulatory body established by the Medicines and Allied

More information

GUIDELINES FOR MEDICAL DEVICES REGISTRATION

GUIDELINES FOR MEDICAL DEVICES REGISTRATION GUIDELINES FOR MEDICAL DEVICES REGISTRATION FOREWORD The purpose of Drug Registration is to ensure that a pharmaceutical product has been adequately tested and evaluated for safety, efficacy and quality,

More information

Kingdom of Swaziland Ministry of Health. Guidelines on Import Procedures for Medicines

Kingdom of Swaziland Ministry of Health. Guidelines on Import Procedures for Medicines Kingdom of Swaziland Ministry of Health Guidelines on Import Procedures for Medicines August 2012 Kingdom of Swaziland Guidelines on Import Procedures for Medicines August 2012 Ministry of Health P. O.

More information

Pharmaceutical Regulatory Authority GUIDELINE ON APPLICATION FOR REGISTRATION OF UNREGISTERED VETERINARY MEDICINES ALREADY ON THE ZAMBIAN MARKET

Pharmaceutical Regulatory Authority GUIDELINE ON APPLICATION FOR REGISTRATION OF UNREGISTERED VETERINARY MEDICINES ALREADY ON THE ZAMBIAN MARKET GUIDELINE ON APPLICATION FOR REGISTRATION OF UNREGISTERED VETERINARY MEDICINES ALREADY ON THE ZAMBIAN MARKET ABBREVIATIONS µg Microgram API Active Pharmaceutical Ingredient ATC Anatomic Therapeutic Chemical

More information

Guidelines on import procedures for pharmaceutical products

Guidelines on import procedures for pharmaceutical products Guidelines on import procedures for pharmaceutical products INTRODUCTION Public health concerns demand that the manufacture of pharmaceutical products and their subsequent handling within the distribution

More information

GUIDELINES FOR MEDICINAL PRODUCT REGISTRATION

GUIDELINES FOR MEDICINAL PRODUCT REGISTRATION GUIDELINES FOR MEDICINAL PRODUCT REGISTRATION TABLE OF CONTENTS Foreword (Pages 3-4) Requirements for submission of product application (Pages 5-19) Dossier requirement (content of a Dossier) for registration

More information

GUIDELINE FOR REGISTRATION OF MEDICINES

GUIDELINE FOR REGISTRATION OF MEDICINES MEDICINES CONTROL AGENCY 54 Kairaba Avenue, Pipeline, The Gambia. Tel.no. +220 4380632 GUIDELINE FOR REGISTRATION OF MEDICINES Document number: MCA-GL-102 Date of issue: 12 February 2018 Version: 2.0 Date

More information

Revision: 00 Page 1 of 6 Date:

Revision: 00 Page 1 of 6 Date: INSPECTION GUIDELINE TITLE: GUIDELINES FOR INSPECTION OF IMPORTED MEDICAL DEVICES, FOOD SUPPLEMENTS, MEDICAL COSMETICS, HERBAL PRODUCTS AND OTHER BORDERLINE PRODUCTS AUTHOR: KEBS AND PPB NO. OF APPENDICES:

More information

Ordinance on the Fees charged by the Swiss Agency for Therapeutic Products (Therapeutic Products Fees Ordinance)

Ordinance on the Fees charged by the Swiss Agency for Therapeutic Products (Therapeutic Products Fees Ordinance) Ordinance on the Fees charged by the Swiss Agency for Therapeutic Products (Therapeutic Products Fees Ordinance) of 2 December 2011 (Stand am 1. Januar 2015) The Agency Council of the Swiss Agency for

More information

IMPORT GUIDELINES, PROCEDURES AND DOCUMENTATION REQUIREMENTS UNDER THE DESTINATION INSPECTION SCHEME IN NIGERIA

IMPORT GUIDELINES, PROCEDURES AND DOCUMENTATION REQUIREMENTS UNDER THE DESTINATION INSPECTION SCHEME IN NIGERIA The below Import Guidelines and attached Transitional Arrangements have been published by the Nigeria Federal Ministry of Finance and Central Bank of Nigeria to cover the import procedures for the Destination

More information

The Pharmacy Council under sections 93 and 95 of the Health Professions Regulatory Bodies Act, 2013 (Act 857), grant licences to Pharmacies

The Pharmacy Council under sections 93 and 95 of the Health Professions Regulatory Bodies Act, 2013 (Act 857), grant licences to Pharmacies 1.0 INTRODUCTION The Pharmacy Council under sections 93 and 95 of the Health Professions Regulatory Bodies Act, 2013 (Act 857), grant licences to Pharmacies The Pharmacy Council issues two types of pharmacy

More information

Application for registration certificate to operate a retail pharmacy 5, ,000.00

Application for registration certificate to operate a retail pharmacy 5, ,000.00 Appendix 3: Pharmaceutical Regulatory Authority Schedule of Fees, 2010 A. RETAIL / HOSPITAL PHARMACY FEE UNITS (1 fee Unit = K180) APPLICATION FEES (ZMK) 1 2 Application for registration certificate to

More information

GUIDELINES FOR CONDUCTING CLINICAL TRIALS.

GUIDELINES FOR CONDUCTING CLINICAL TRIALS. GUIDELINES FOR CONDUCTING CLINICAL TRIALS. FOREWORD The purpose of Drug Registration is to ensure that a pharmaceutical product has been adequately tested and evaluated for safety, efficacy and quality,

More information

On Approval of the Rules on Importation and Exportation of Medicines, Products of Medical Purposes and Medical Equipment

On Approval of the Rules on Importation and Exportation of Medicines, Products of Medical Purposes and Medical Equipment On Approval of the Rules on Importation and Exportation of Medicines, Products of Medical Purposes and Medical Equipment Resolution of the Government of the Republic of Kazakhstan No. 711 of 31 May 2012

More information

Regulation Regarding the Packaging and Labeling of Medicinal Products for Human Use

Regulation Regarding the Packaging and Labeling of Medicinal Products for Human Use Regulation Regarding the Packaging and Labeling of Medicinal Products for Human Use, 01.02.2008, ENG The amendments made with the Regulation Amending the Regulation Regarding the Packaging and Labeling

More information

Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products

Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products March 2014 Table of Content INTRODUCTION 3 Section 1: GENERAL RESPONSIBILITIES OF HOLDER

More information

Country presentation MAURITIUS

Country presentation MAURITIUS Country presentation MAURITIUS GALVmed/OIE Stakeholder Workshop On The Harmonisation Of The Registration Of Veterinary Medicinal Products JOHANNESBURG 09-11 May 2017 STATUS OF REQUIREMENTS FOR REGISTRATION

More information

[Rev. 2012] CAP. 336 Dairy Industry

[Rev. 2012] CAP. 336 Dairy Industry DAIRY INDUSTRY (IMPORTS AND EXPORTS) REGULATIONS ARRANGEMENT OF REGULATIONS Regulation 1. Citation. 2. Permit required for import and export. 3. Application for a permit. 4. Form of permit. 5. Fees. 6.

More information

APPLICATION FOR MARKETING AUTHORIZATION OF A PHARMACEUTICAL PRODUCT FOR HUMAN USE IN UGANDA

APPLICATION FOR MARKETING AUTHORIZATION OF A PHARMACEUTICAL PRODUCT FOR HUMAN USE IN UGANDA National Drug Authority Plot No. 46-48 Lumumba Avenue, P.O. Box 23096, Kampala, Uganda. email: ndaug@nda.or.ug; website: www.nda.or.ug Doc. No.: DAR/FOM/170 Revision No.: 1 Effective Date: 21 June 2016

More information

GUIDELINES FOR INTRODUCING A LOCALLY MANUFACTURED NEW PHARMACEUTICAL PRODUCT ON THE UGANDA MARKET

GUIDELINES FOR INTRODUCING A LOCALLY MANUFACTURED NEW PHARMACEUTICAL PRODUCT ON THE UGANDA MARKET GUIDELINES FOR INTRODUCING A LOCALLY MANUFACTURED NEW PHARMACEUTICAL PRODUCT ON THE UGANDA MARKET National Drug Authority Head Office Rumee Towers Plot 19, Lumumba Avenue P. O. Box 23096 Kampala, Uganda

More information

Registration Application form for Vaccines (To be submitted in duplicate electronic copies)

Registration Application form for Vaccines (To be submitted in duplicate electronic copies) Cover letter addressed to: Registration Application form for Vaccines (To be submitted in duplicate electronic copies) THE CHIEF EXECUTIVE FOOD AND DRUGS AUTHORITY P. O. BOX CT 2783 CANTONMENTS-ACCRA GHANA.

More information

THE TANZANIA FOOD, DRUGS AND COSMETICS ACT, (CAP. 219) REGULATIONS. (Made under Section 122(1)(e))

THE TANZANIA FOOD, DRUGS AND COSMETICS ACT, (CAP. 219) REGULATIONS. (Made under Section 122(1)(e)) GOVERNMENT NOTICE 312 published on 31/07/2015 THE TANZANIA FOOD, DRUGS AND COSMETICS ACT, (CAP. 219) REGULATIONS (Made under Section 122(1)(e)) THE TANZANIA FOOD, DRUGS AND COSMETICS (REGISTRATION OF PREMISES,

More information

APPLICATION FOR INTERNATIONAL TRADE CERTIFICATE FOR NATURAL HEALTH PRODUCTS

APPLICATION FOR INTERNATIONAL TRADE CERTIFICATE FOR NATURAL HEALTH PRODUCTS APPLICATION FOR INTERNATIONAL TRADE CERTIFICATE FOR NATURAL HEALTH PRODUCTS NATURAL HEALTH PRODUCTS DIRECTORATE November 2007 Version 2.0 Our mission is to help the people of Canada maintain and improve

More information

CGMP Requirements for Investigational Products

CGMP Requirements for Investigational Products PREP #6 CGMP Requirements for Investigational Products Ji-Eun Kim, RPh, PhD Research Pharmacist Regulatory Affairs Office of Research Compliance December 6, 2016 1 CME Disclosure Statement Northwell Health

More information

JAMIA HAMDARD HAH CENTENARY HOSPITAL HAMDARD NAGAR, NEW DELHI Phone : , Extn 5326 Website :

JAMIA HAMDARD HAH CENTENARY HOSPITAL HAMDARD NAGAR, NEW DELHI Phone : , Extn 5326 Website : Phone : 26059688, Extn 5326 Website : www.jamiahamdard.edu NOTICE INVITING TENDER Sealed tenders are invited from the manufacturers / authorized distributors / importers for annual rate contract for the

More information

REPUBLIC OF MAURITIUS APPLICATION FOR REGISTRATION OF A DRUG

REPUBLIC OF MAURITIUS APPLICATION FOR REGISTRATION OF A DRUG SCHEDULE Form 1 REPUBLIC OF MAURITIUS APPLICATION FOR REGISTRATION OF A DRUG THE REGISTRAR PHARAMCY BOARD MINISTRY OF HEALTH AND QUALITY OF LIFE MAURITIUS Fax: Telephone: TYPE OF APPLICATION HUMAN, BIOLOGICAL

More information

I. Purpose. II. Definitions. Last Approval Date

I. Purpose. II. Definitions. Last Approval Date Investigational Drugs and Biologics Page 1 of 13 I. Purpose The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics

More information

Vendor Registration Application Form

Vendor Registration Application Form Vendor Registration Application Form Hospitals must complete the Vendor Registration Application Form in full together with all the required supporting documentation. SECTION 1 VENDOR NUMBER HOSPITAL OR

More information

Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland

Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland IA-G0008-5 17 JUNE 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance

More information

PHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR RECALL OF MEDICINES AND HEALTH PRODUCTS IN MALAWI

PHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR RECALL OF MEDICINES AND HEALTH PRODUCTS IN MALAWI PHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR RECALL OF MEDICINES AND HEALTH PRODUCTS IN MALAWI Draft September 2015 1. INTRODUCTION The Malawi Pharmacy Medicines and Poisons Board (PMPB) was established

More information

MINISTRY OF PUBLIC HEALTH GENERAL SECRETARIAT MADAGASCAR DRUG S AGENCY EDÑ Ì ÑFG EFÌGD EÌD

MINISTRY OF PUBLIC HEALTH GENERAL SECRETARIAT MADAGASCAR DRUG S AGENCY EDÑ Ì ÑFG EFÌGD EÌD MINISTRY OF PUBLIC HEALTH EDÑ Ì ÑFG GENERAL SECRETARIAT EFÌGD MADAGASCAR DRUG S AGENCY EÌD 2013 VERSION 1 INTRODUCTION Registration of drugs is one of the basic activities of regulatory health authorities.

More information

Russian Federation. Chapter 12. By Julianna Tabastajewa and Svetlana Rudevich

Russian Federation. Chapter 12. By Julianna Tabastajewa and Svetlana Rudevich Chapter 12 Russian Federation By Julianna Tabastajewa and Svetlana Rudevich Legal System The Russian Federation is a federal state consisting of a total of 83 republics, regions, federal cities, autonomous

More information

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE Medical Device Product Questionnaire This questionnaire is used to collect information from vendors with regards to medical devices that fall in any of the

More information

Guidelines for application for Registration of Medicinal Products 2006(DRA)

Guidelines for application for Registration of Medicinal Products 2006(DRA) Contact details: Drug Regulatory Authority, Thimphu Bhutan Telephone # 00975-2-334271, Fax: 00975-2-335803 Email : dra@health.gov.bt URL : www.health.gov.bt/dra.php Page 1 of 10 The guidelines outlined

More information

i t i s d e c r e e d a s f o l l o w s:

i t i s d e c r e e d a s f o l l o w s: License for the manufacture of drugs for the import of drugs for the wholesale trade of drugs Facts and circumstances Renewal of the license issued on 16 December 2010 for the company,,, company number

More information

KENYA BUREAU OF STANDARDS Pre-Export Verification of Conformity to Standards

KENYA BUREAU OF STANDARDS Pre-Export Verification of Conformity to Standards INTRODUCTION The Kenyan Bureau of Standards (KEBS), a statutory organization of the government of Kenya, is responsible for the adoption and application of Standards for both imported and domestically

More information

BY THE BLESSINGS OF ALMIGHTY GOD THE MINISTER OF HEALTH OF THE REPUBLIC OF INDONESIA,

BY THE BLESSINGS OF ALMIGHTY GOD THE MINISTER OF HEALTH OF THE REPUBLIC OF INDONESIA, REGULATION OF THE MINISTER OF HEALTH OF THE REPUBLIC OF INDONESIA NUMBER 3 OF 2015 ON CIRCULATION, STORAGE, DESTRUCTION AND REPORTING OF NARCOTICS, PSYCHOTROPICS AND PHARMACY PRECURSORS BY THE BLESSINGS

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL LICENCE APPLICATION TO ACT AS WHOLESALER of MEDICAL DEVICES and IVDs An application form for the purpose of obtaining a licence or renewing an existing licence in terms of the

More information

MEDICINES CONTROL AUTHORITY OF ZIMBABWE (MCAZ) Guidelines for the Notification of a Medicinal Product Problem/Defect and Recall Procedure

MEDICINES CONTROL AUTHORITY OF ZIMBABWE (MCAZ) Guidelines for the Notification of a Medicinal Product Problem/Defect and Recall Procedure MEDICINES CONTROL AUTHORITY OF ZIMBABWE (MCAZ) Guidelines for the Notification of a Medicinal Product Problem/Defect and Recall Procedure FEBRUARY 2016 Medicines Control Authority of Zimbabwe, 106 Baines

More information

Kansas Pharmacy Act Amendments; Filling and Refilling Prescriptions; Biological Products; Senate Sub. for HB 2055

Kansas Pharmacy Act Amendments; Filling and Refilling Prescriptions; Biological Products; Senate Sub. for HB 2055 Kansas Pharmacy Act Amendments; Filling and Refilling Prescriptions; Biological Products; Senate Sub. for HB 2055 (Act). Senate Sub. for HB 2055 makes several amendments to the Kansas Pharmacy Act The

More information

DRUG REGULATORY PROCEDURES IN TANZANIA: A GLIMPSE

DRUG REGULATORY PROCEDURES IN TANZANIA: A GLIMPSE DRUG REGULATORY PROCEDURES IN TANZANIA A GLIMPSE Available online at www.ijdra.com REVIEW ARTICLE Jain Achin*, Venkatesh M P, Pramod Kumar T M. JSS College of Pharmacy, JSS University, S.S. Nagar, Mysore-570015,

More information

STANDARDS ORGANISATION OF NIGERIA

STANDARDS ORGANISATION OF NIGERIA INTRODUCTION TO THE NEW SONCAP PROGRAMME The Nigerian Standards Organisation of the Federal Republic of Nigeria is responsible for the preparation, adoption and application of Standards for both imported

More information

Kingdom of Cambodia National Religion King ANUKRET ON STANDARDS AND MANAGEMENT OF AGRICULTURAL MATERIALS. The Royal Government of Cambodia

Kingdom of Cambodia National Religion King ANUKRET ON STANDARDS AND MANAGEMENT OF AGRICULTURAL MATERIALS. The Royal Government of Cambodia Filename: 08 ANK-Pesticide.doc Kingdom of Cambodia National Religion King Royal Government of Cambodia No. 69/ANK/BK ANUKRET ON STANDARDS AND MANAGEMENT OF AGRICULTURAL MATERIALS The Royal Government of

More information

UGANDA NATIONAL BUREAU OF STANDARDS CERTIFICATION SCHEME

UGANDA NATIONAL BUREAU OF STANDARDS CERTIFICATION SCHEME 1. NAME AND ADDRESS OF APPLICANT Company Name Company Tax Identification Number (TIN) A. APPLICANT S INFORMATION Business Registration Please attach certificate of registration of business COMPANY ADDRESS

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL EDICINES CONTROL COUNCIL LICENCE APPLICATION TO ANUFACTURE, IPORT OR EXPORT EDICINE An application form for the purpose of obtaining a licence or renewing a licence in terms of the provisions of the edicines

More information

Romania. Raluca Vasilescu Cabinet M Oproiu. Pharmaceutical Trademarks 2015/2016. A Global Guide

Romania. Raluca Vasilescu Cabinet M Oproiu. Pharmaceutical Trademarks 2015/2016. A Global Guide Romania Raluca Vasilescu Cabinet M Oproiu Pharmaceutical Trademarks 2015/2016 A Global Guide Romania Cabinet M Oproiu Author Raluca Vasilescu Selection, clearance and registration In Romania, pharmaceutical

More information

HIV/AIDS Programme USER GUIDE DRUG REGULATORY STATUS DATABASE (DRS) Version 2

HIV/AIDS Programme USER GUIDE DRUG REGULATORY STATUS DATABASE (DRS) Version 2 HIV/AIDS Programme USER GUIDE DRUG REGULATORY STATUS DATABASE (DRS) Version 2 November 2012 HIV/AIDS Programme USER GUIDE DRUG REGULATORY STATUS DATABASE (DRS) Version 2 November 2012 WHO Library Cataloguing-in-Publication

More information

STANDARDS ORGANISATION OF NIGERIA

STANDARDS ORGANISATION OF NIGERIA ISSUED: 09-Oct-13 INTRODUCTION TO THE NEW SONCAP PROGRAMME The Nigerian Standards Organisation of the Federal Republic of Nigeria is responsible for the preparation, adoption and application of Standards

More information

Republic of the Philippines Department of Health OFFICE OF THE SECRETARY M a n i l a

Republic of the Philippines Department of Health OFFICE OF THE SECRETARY M a n i l a Republic of the Philippines Department of Health OFFICE OF THE SECRETARY M a n i l a March 15, 1989 ADMINISTRATIVE ORDER No. 67 s. 1989 SUBJECT: Revised Rules and Regulations on Registration of Pharmaceutical

More information

Building Effective National Strategies to Better Address Counterfeit Medicines

Building Effective National Strategies to Better Address Counterfeit Medicines Building Effective National Strategies to Better Address Counterfeit Medicines Expanding GMP, GDP, GPP, and Pharmacovigilance Systems ILISA B.G. BERNSTEIN, Pharm.D., J.D. Director of Pharmacy Affairs U.S.

More information

No. : 665/6927 Date : April 16, 2016 To : All pharmaceutical companies

No. : 665/6927 Date : April 16, 2016 To : All pharmaceutical companies No. : 665/6927 Date : April 16, 2016 To : All pharmaceutical companies Respectfully; In the name of God Islamic Rep. of Iran Food & Drug Administration Gen. Dept. of Supervision & Evaluation of Drug &

More information

DRUGS CONTROL ORGANISATION

DRUGS CONTROL ORGANISATION DRUGS CONTROL ORGANISATION Medical & health Department, Swasthya Bhawan, Tilak Marg Jaipur Email address- drugscontrolraj@gmail.com Phone - 01412221760 Check List for documents to be submitted for Grant

More information

CHAPTER THE PHARMA LEGAL HANDBOOK SOUTH AFRICA

CHAPTER THE PHARMA LEGAL HANDBOOK SOUTH AFRICA CHAPTER THE PHARMA LEGAL HANDBOOK SOUTH AFRICA THE PHARMA LEGAL HANDBOOK ANSWERS ESSENTIAL QUESTIONS ABOUT THE LEGAL AND REGULATORY ENVIRONMENT FOR PHARMACEUTICALS IN SOUTH AFRICA. IT IS A MUST-HAVE FOR

More information

Decree of General Administration of Quality Supervision, Inspection. and Quarantine of the People s Republic of China. No. 135

Decree of General Administration of Quality Supervision, Inspection. and Quarantine of the People s Republic of China. No. 135 Decree of General Administration of Quality Supervision, Inspection and Quarantine of the People s Republic of China No. 135 The Administrative Measures of Inspection, Quarantine and Supervision on Import

More information

Title: Department: Approved by: Director, Human Research Review and Compliance

Title: Department: Approved by: Director, Human Research Review and Compliance Title: Department: Requirements for Investigational New Drug (IND) for Human- Subjects Research Human Research Affairs Policy Type: Partners System-wide Partners System-wide Template Partners HealthCare

More information

MEDICINES CONTROL AGENCY. Guideline for Safe Disposal of Medicines and Related Products

MEDICINES CONTROL AGENCY. Guideline for Safe Disposal of Medicines and Related Products MEDICINES CONTROL AGENCY Guideline for Safe Disposal of Medicines and Related Products FORWARD The Medicines Control Agency (MCA) established by an Act of Parliament and assented to on 24th December 2014

More information

Doc. No. DPS/GDL/034 Revision No.: 0 Effective Date: 26 April 2018 Review-Due Date: 26 April 2021

Doc. No. DPS/GDL/034 Revision No.: 0 Effective Date: 26 April 2018 Review-Due Date: 26 April 2021 National Drug Authority Head Office Rumee Towers Plot 19, Lumumba Avenue P. O. Box 23096 Kampala, Uganda Tel: 256-0414 - 255665/347391/2 E-mail: ndaug@nda.or.ug Website: http://www.nda.or.ug Doc. No. DPS/GDL/034

More information

REGULATION (EC) No 542/95

REGULATION (EC) No 542/95 REGULATION (EC) No 542/95 Commission Regulation (EC) No 542/95 of 10 March 1995 concerning the examination of variations to the terms of a marketing authorization falling within the scope of Council Regulation

More information

No April 2018 TARIFF

No April 2018 TARIFF DISCLAIMER: This text is an informal translation of Tariff No 404/2018. TARIFF for marketing authorisations, annual fees and other licence fees for medicinal products and other related products, collected

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MODULE 1 1.2.1 MEDICINES CONTROL COUNCIL APPLICATION FOR REGISTRATION OF A MEDICINE 1 Module 1: Administrative Information Application Form This application form will be included in the South African Common

More information

Guide to Scientific and Regulatory Advice for GXP activities

Guide to Scientific and Regulatory Advice for GXP activities Guide to Scientific and Regulatory Advice for GXP activities ADV-G0019-1 7 OCTOBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only.

More information

A SHORT GUIDE TO THE PROCEDURE FOR A CLINICAL TRIAL APPLICATION IN THE KINGDOM OF BAHRAIN

A SHORT GUIDE TO THE PROCEDURE FOR A CLINICAL TRIAL APPLICATION IN THE KINGDOM OF BAHRAIN A SHORT GUIDE TO THE PROCEDURE FOR A CLINICAL TRIAL APPLICATION IN THE KINGDOM OF BAHRAIN Version 1 - June 2017 A Short Guide For CT Application 1 2 A Short Guide For CT Application DEFINITIONS Clinical

More information

G/TBT/N/MYS/8 Proposal to enforce the Control of Drugs and Cosmetics Regulations 1984 on veterinary medicinal products.

G/TBT/N/MYS/8 Proposal to enforce the Control of Drugs and Cosmetics Regulations 1984 on veterinary medicinal products. G/TBT/N/MYS/8 Proposal to enforce the Control of Drugs and Cosmetics Regulations 1984 on veterinary medicinal products. The Health Minister of Malaysia, as conferred by subregulation 1(2) of the Control

More information

Introduction of OTC switch in China. Han Qing Regulatory Affairs of One China OTC J&J Oct

Introduction of OTC switch in China. Han Qing Regulatory Affairs of One China OTC J&J Oct Introduction of OTC switch in China Han Qing Regulatory Affairs of One China OTC J&J Oct 22 2014 Outline Regulatory History Classification Switch Challenges Regulatory History 3 stages Stage 1: before

More information

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Key Topics Definitions Essential Principles Classification Conformity Assessment Framework License to Manufacture, Import,

More information

Is FMT A Drug? Lance Shea, M.S., J.D. Washington Square, Suite Connecticut Ave., NW Washington, DC, D

Is FMT A Drug? Lance Shea, M.S., J.D. Washington Square, Suite Connecticut Ave., NW Washington, DC, D Is FMT A Drug? Lance Shea, M.S., J.D. Washington Square, Suite 1100 1050 Connecticut Ave., NW Washington, DC, 20036 D 202-861-1648 LShea@bakerlaw.com FMT Scenarios Intra-Office Bank Product The Issue The

More information

MINISTRY OF HEALTH ORDINANCE

MINISTRY OF HEALTH ORDINANCE MINISTRY OF HEALTH 1799 Pursuant to Article 73, paragraph 2, Article 74, paragraph 2 and Article 89, paragraph 2 of the Medicinal Products Act (Official Gazette 76/2013), the Minister of Health hereby

More information

Overview of global registration of vaccines

Overview of global registration of vaccines Overview of global registration of vaccines by Dr. Nora Dellepiane Workshop: Global Registration and Vaccine Shortage Taipei, Taiwan 6 to 10 March 2017 Outline of the presentation The objective of medicines

More information

SUPPLIER DATABASE FOR TSHWANE RAPID TRANSIT (PTY) LTD

SUPPLIER DATABASE FOR TSHWANE RAPID TRANSIT (PTY) LTD 1 SUPPLIER DATABASE FOR TSHWANE RAPID TRANSIT (PTY) LTD Tshwane Rapid Transit (Pty) Ltd invites companies to register on our supplier database for provision of specified goods and services. The supplier

More information

Local Pharmaceutical Manufacturer Licensing Procedure

Local Pharmaceutical Manufacturer Licensing Procedure Local Pharmaceutical Manufacturer Licensing Procedure National Health Regulatory Authority (NHRA) Kingdom of Bahrain October 2017 Version 1.3 1 1. Introduction This document is meant to provide assistance

More information

Di Renzo Regulatory Affairs ROME - MILAN - LONDON

Di Renzo Regulatory Affairs ROME - MILAN - LONDON Di Renzo Regulatory Affairs ROME - MILAN - LONDON Di Renzo Regulatory Affairs In 1985, Di Renzo Regulatory Affairs began its regulatory consulting for medicines for human and veterinary use, food and dietary

More information

TANZANIA BUREAU OF STANDARDS Pre-Export Verification of Conformity to Standards

TANZANIA BUREAU OF STANDARDS Pre-Export Verification of Conformity to Standards INTRODUCTION The Bureau of Standards (TBS) was established by Act of Parliament in 1975 which was subsequently amended in 1977. TBS is a specialized parastatal organization servicing in the field of standardization,

More information

GUIDANCE FOR INDUSTRY. Questions and Answers

GUIDANCE FOR INDUSTRY. Questions and Answers GUIDANCE FOR INDUSTRY Prescription Drug Marketing Act (PDMA) Requirements Questions and Answers U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and

More information

SUPPLEMENTAL NOTE ON HOUSE BILL NO. 2055

SUPPLEMENTAL NOTE ON HOUSE BILL NO. 2055 Brief* SESSION OF 2017 SUPPLEMENTAL NOTE ON HOUSE BILL NO. 2055 As Recommended by House Committee on Health and Human Services HB 2055 would amend the Kansas Pharmacy Act (Act) by deleting, adding, and

More information

Pharmaceutical law legal FramewOrK

Pharmaceutical law legal FramewOrK Pharmaceutical law LEGAL FRAMEWORK 2015 CONTENTS: Hardly any area of law has such a direct connection to human health as pharmaceutical law. This fact requires fulfillment of detailed and strict conditions

More information

Supply of aseptically - prepared doses of IMPs across legal boundaries. Edition 1. December 2017

Supply of aseptically - prepared doses of IMPs across legal boundaries. Edition 1. December 2017 Supply of aseptically - prepared doses of IMPs across legal boundaries Edition 1 December 2017 Endorsed and supported by: NHS Pharmaceutical Quality Assurance Committee 2017 with National Pharmacy Clinical

More information

Tanzania Food, Drugs And Cosmetics (Clinical Trials Control) THE TANZANIA FOOD, DRUGS AND COSMETICS ACT ARRANGEMENT OF REGULATIONS

Tanzania Food, Drugs And Cosmetics (Clinical Trials Control) THE TANZANIA FOOD, DRUGS AND COSMETICS ACT ARRANGEMENT OF REGULATIONS GOVERNMENT NOTICE NO. 53.published on 15/03/2013 THE TANZANIA FOOD, DRUGS AND COSMETICS ACT ARRANGEMENT OF REGULATIONS Regulation Title PART I PRELIMINARY PROVISIONS 1. Short title and commencement. 2.

More information

USER MANUAL. This document details the applications and procedures with regards to the exporting of Liquor Products on Wine Online.

USER MANUAL. This document details the applications and procedures with regards to the exporting of Liquor Products on Wine Online. USER MANUAL 7 May 2010 Export Manual This document details the applications and procedures with regards to the exporting of Liquor Products on Wine Online. Authors: Wendy Jonker Version: 1.1 System specification

More information

Internationally harmonised requirements for batch certification

Internationally harmonised requirements for batch certification 1 June 2011 EMA/INS/MRA/387218/2011 Rev 5 Compliance and Inspection Internationally harmonised requirements for batch certification in the context of Mutual Recognition Agreements, Agreements on Conformity

More information

FOOD AND DRUGS AUTHORITY

FOOD AND DRUGS AUTHORITY FOOD AND DRUGS AUTHORITY APPLICATION FORM FOR REGISTRATION OF MEDICAL DEVICES Document No. : FDA/MCH/MDD/AP-IMD/2013/02 Date of First Adoption : 1st February, 2013 Date of Issue : 1st March, 2013 Version

More information

Medical Devices. LATVIA LAWIN Klavins & Slaidins

Medical Devices. LATVIA LAWIN Klavins & Slaidins Medical Devices LATVIA LAWIN Klavins & Slaidins CONTACT INFORMATION Sarmis Spilbergs LAWIN Klavins & Slaidins Elizabetes 15, Riga, LV 1010, Latvia +371 67814848 sarmis.spilbergs@lawin.lv www.lawin.com

More information

Approved by Resolution of the Ministry of Health of the Republic of Belarus No. 55 dated April 23, 2015

Approved by Resolution of the Ministry of Health of the Republic of Belarus No. 55 dated April 23, 2015 RESOLUTION of the Ministry of Health of the Republic of Belarus No. 55 dated April 23, 2015 On certain measures on realization of the Resolution of the Council of Ministers of the Republic of Belarus No.

More information

MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS

MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS ANNEX 13 MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS Introduction Medicinal products intended for research and development trials are not at present subject either to marketing or manufacturing Community

More information

75th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. Senate Bill 676 CHAPTER... AN ACT

75th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. Senate Bill 676 CHAPTER... AN ACT 75th OREGON LEGISLATIVE ASSEMBLY--2009 Regular Session Sponsored by Senators PROZANSKI, NELSON Enrolled Senate Bill 676 CHAPTER... AN ACT Relating to industrial hemp; creating new provisions; amending

More information

Earlsfort Centre Earlsfort Terrace Dublin 2 Ireland

Earlsfort Centre Earlsfort Terrace Dublin 2 Ireland Earlsfort Centre Earlsfort Terrace Dublin 2 Ireland GUIDANCE NOTE ON THE WHOLESALING OF MEDICINAL PRODUCTS FOR HUMAN USE IN IRELAND OCTOBER 2004 This guidance note does not purport to be the definitive

More information

Agreement between Japan and the Socialist Republic of Viet Nam for an Economic Partnership

Agreement between Japan and the Socialist Republic of Viet Nam for an Economic Partnership Agreement between Japan and the Socialist Republic of Viet Nam for an Economic Partnership IMPLEMENTING REGULATIONS This Implementing Regulations should be applied to the pertinent provisions in the Schedule

More information

Registration and renewal of the credential certificate for registration

Registration and renewal of the credential certificate for registration Registration and renewal of the credential certificate for registration 1. Qualification of the applicant: 1.1 Must be a holder of the license to manufacture or import the psychotropic substances of category

More information

Customs-related aspects of the Rotterdam Convention Switzerland s experience. Secretariat of the Rotterdam Convention. Switzerland s experience

Customs-related aspects of the Rotterdam Convention Switzerland s experience. Secretariat of the Rotterdam Convention. Switzerland s experience ROTTERDAM CONVENTION Case study on the Customs-related aspects of the Rotterdam Convention Switzerland s experience 1 Secretariat of the Rotterdam Convention TABLE OF CONTENTS 1.0 BACKGROUND. page 1 2.0

More information

IMPLEMENTATION OF THE EU FALSIFIED MEDICINES DIRECTIVE, 2011/62/EU. IPA/EDQM/WHO 2012, Mumbai

IMPLEMENTATION OF THE EU FALSIFIED MEDICINES DIRECTIVE, 2011/62/EU. IPA/EDQM/WHO 2012, Mumbai IMPLEMENTATION OF THE EU FALSIFIED MEDICINES DIRECTIVE, 2011/62/EU from the perspective of Indian manufacturers and Indian authorities IPA/EDQM/WHO 2012, Mumbai S.M.MUDDA Micro Labs Limited, Bangalore

More information

1.4 Applicable Regulatory Requirement(s) Any law(s) and regulation(s) addressing the conduct of clinical trials of investigational products.

1.4 Applicable Regulatory Requirement(s) Any law(s) and regulation(s) addressing the conduct of clinical trials of investigational products. 1.1 Adverse Drug Reaction (ADR) In the pre-approval clinical experience with a new medicinal product or its new usages, particularly as the therapeutic dose(s) may not be established: all noxious and unintended

More information

Review of fees payable under the Medicines Regulations 1984

Review of fees payable under the Medicines Regulations 1984 Review of fees payable under the Medicines Regulations 1984 Consultation document Medsafe March 2018 Page 1 of 19 Contents INTRODUCTION... 3 Purpose and scope... 3 Background... 3 Why are the fees being

More information

State Control of Medicines and Medical Devices in Russian Federation

State Control of Medicines and Medical Devices in Russian Federation Federal Service for Surveillance in Healthcare State Control of Medicines and Medical Devices in Russian Federation Ph.D., Elena Astapenko The Head of the Department of organization of state control and

More information

Regulation issued by the Federal Office for Safety in Health Care regarding the Schedule of Fees pursuant to the GESG

Regulation issued by the Federal Office for Safety in Health Care regarding the Schedule of Fees pursuant to the GESG Please be aware that we cannot guarantee the correctness of the translation. To make sure, you have the correct and complete version, please look at the German version of the official announcements of

More information

Regulation issued by the Federal Office for Safety in Health Care regarding the Schedule of Fees pursuant to the GESG

Regulation issued by the Federal Office for Safety in Health Care regarding the Schedule of Fees pursuant to the GESG Please be aware that we cannot guarantee the correctness of the translation. To make sure, you have the correct and complete version, please look at the German version of the official announcements of

More information

Korea GMP & DMF. April Korea Pharmaceutical Traders Association Deputy director Oh Hyun, Kwon

Korea GMP & DMF. April Korea Pharmaceutical Traders Association Deputy director Oh Hyun, Kwon Korea GMP & DMF April. 2015 Korea Pharmaceutical Traders Association Deputy director Oh Hyun, Kwon Contents 1. KPTA 2. Pharmaceutical industry 3. KGMP 4. KDMF KPTA KPTA Purpose ㅇ Trade promotion of pharmaceuticals,

More information

Membership Registration Form. Company Details

Membership Registration Form. Company Details Membership Registration Form This form allows you to become a voting or non-voting member of GS1 Healthcare, the global healthcare user group. GS1 Healthcare welcomes the following stakeholders as voting

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Licence to act as a Wholesaler or Distributor MEDICINES CONTROL COUNCIL GUIDELINES FOR LICENCE TO ACT AS A WHOLESALER or DISTRIBUTOR This guideline is intended to provide recommendations to applicants

More information

APPENDIX C ADDITIONAL TERMS AND CONDITIONS PERTAINING TO FOREIGN PROCUREMENTS

APPENDIX C ADDITIONAL TERMS AND CONDITIONS PERTAINING TO FOREIGN PROCUREMENTS APPENDIX C ADDITIONAL TERMS AND CONDITIONS PERTAINING TO FOREIGN PROCUREMENTS I. PROVISIONS APPLICABLE TO GOODS BEING IMPORTED INTO THE UNITED STATES WITH ASSISTS PROVIDED BY BUYER A. APPLICABILITY This

More information

NEW YORK STATE BAR ASSOCIATION FOOD, DRUG AND COSMETIC LAW SECTION AND HEALTH LAW SECTION COMMITTEE ON MEDICAL RESEARCH AND BIOTECHNOLOGY

NEW YORK STATE BAR ASSOCIATION FOOD, DRUG AND COSMETIC LAW SECTION AND HEALTH LAW SECTION COMMITTEE ON MEDICAL RESEARCH AND BIOTECHNOLOGY NEW YORK STATE BAR ASSOCIATION FOOD, DRUG AND COSMETIC LAW SECTION AND HEALTH LAW SECTION COMMITTEE ON MEDICAL RESEARCH AND BIOTECHNOLOGY MEMORANDUM IN SUPPORT OF AN AMENDMENT TO NEW YORK S PHARMACY LAW

More information